Literature DB >> 20639054

Prominent expression of phosphodiesterase 5 in striated muscle of the rat urethra and levator ani.

Guiting Lin1, Yun-Ching Huang, Guifang Wang, Tom F Lue, Ching-Shwun Lin.   

Abstract

PURPOSE: We investigated phosphodiesterase 5 distribution and activity in the urethra.
MATERIALS AND METHODS: Rat tissues were examined for phosphodiesterase 5 and alpha-smooth muscle actin expression. Urethral phosphodiesterase 5 activity was examined by tissue bath in the presence of sildenafil (Pfizer, New York, New York).
RESULTS: Anti-alpha-smooth muscle actin antibody (Abcam) stained all known smooth muscles in all tested tissues and revealed a few smooth muscle fibers in the levator ani muscle. Anti-phosphodiesterase 5 antibody (Abcam) stained smooth muscle in the penis and bladder but not striated leg muscle. However, it stained predominantly striated muscle in the urethra and the levator ani muscle. In the urethra the amount of phosphodiesterase 5 in striated muscle was 6 times that in smooth muscle. In urethral striated muscle phosphodiesterase 5 expression was localized to Z-band striations. Smooth and striated muscle intermingling was clearly visible on the inner and outer rims of the circularly arranged striated muscle layer. Relaxation of precontracted urethral tissues by sodium nitroprusside (Sigma-Aldrich) was enhanced by sildenafil, indicating phosphodiesterase 5 activity, which was primarily located in the striated muscle according to phosphodiesterase 5 staining.
CONCLUSIONS: Despite its presumed smooth muscle specificity phosphodiesterase 5 was predominantly expressed in the striated muscle of the urethra and in the levator ani muscle. Results are consistent with earlier studies in which these striated muscles were developmentally related to smooth muscle. They also suggest that these striated muscles are possibly regulated by phosphodiesterase 5. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639054      PMCID: PMC3163603          DOI: 10.1016/j.juro.2010.03.110

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  An investigation of the effects of zaprinast, a PDE inhibitor, on the nitrergic control of the urethra in anaesthetized female rats.

Authors:  Alexandra Wibberley; Philip A Nunn; Alasdair M Naylor; Andrew G Ramage
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 2.  Phosphodiesterases as therapeutic targets.

Authors:  Ching-Shwun Lin; Zhong-Cheng Xin; Guiting Lin; Tom F Lue
Journal:  Urology       Date:  2003-04       Impact factor: 2.649

3.  Smooth and striated muscle development in the intrinsic urethral sphincter.

Authors:  S Borirakchanyavat; L S Baskin; B A Kogan; G R Cunha
Journal:  J Urol       Date:  1997-09       Impact factor: 7.450

4.  The anatomical components of urinary continence.

Authors:  Christian Wallner; Noshir F Dabhoiwala; Marco C DeRuiter; Wouter H Lamers
Journal:  Eur Urol       Date:  2008-08-20       Impact factor: 20.096

5.  The female urethral sphincter: a morphological and topographical study.

Authors:  K Colleselli; A Stenzl; R Eder; H Strasser; S Poisel; G Bartsch
Journal:  J Urol       Date:  1998-07       Impact factor: 7.450

6.  Factors maintaining the intraurethral pressure in women.

Authors:  T Rud; K E Andersson; M Asmussen; A Hunting; U Ulmsten
Journal:  Invest Urol       Date:  1980-01

Review 7.  The physiology of the mammalian urinary outflow tract.

Authors:  A F Brading
Journal:  Exp Physiol       Date:  1999-01       Impact factor: 2.969

8.  Nitric oxide synthase in the heterogeneous population of intramural striated muscle fibres of the human membranous urethral sphincter.

Authors:  K M Ho; G McMurray; A F Brading; J G Noble; L Ny; K E Andersson
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

9.  Isolation of two isoforms of phosphodiesterase 5 from rat penis.

Authors:  C-S Lin; G Lin; T F Lue
Journal:  Int J Impot Res       Date:  2003-04       Impact factor: 2.896

Review 10.  Nitric oxide synthase and nitric oxide-mediated effects in lower urinary tract smooth muscles.

Authors:  K E Andersson; K Persson
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

View more
  8 in total

1.  Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy.

Authors:  Jennifer Tinklenberg; Hui Meng; Lin Yang; Fujun Liu; Raymond G Hoffmann; Mahua Dasgupta; Kenneth P Allen; Alan H Beggs; Edna C Hardeman; R Scott Pearsall; Robert H Fitts; Michael W Lawlor
Journal:  Am J Pathol       Date:  2016-04-18       Impact factor: 4.307

Review 2.  The Complex Relationship Between Lower Urinary Tract Symptoms and Sexual Health.

Authors:  Hanson Zhao; Howard H Kim
Journal:  Curr Urol Rep       Date:  2019-08-29       Impact factor: 3.092

3.  Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study.

Authors:  E Cadirci; Z Halici; F Odabasoglu; A Albayrak; E Karakus; D Unal; F Atalay; I Ferah; B Unal
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

4.  Impaired contractility of the circular striated urethral sphincter muscle may contribute to stress urinary incontinence in female zucker fatty rats.

Authors:  Yung-Chin Lee; Guiting Lin; Guifang Wang; Amanda Reed-Maldonado; Zhihua Lu; Lin Wang; Lia Banie; Tom F Lue
Journal:  Neurourol Urodyn       Date:  2016-10-29       Impact factor: 2.696

5.  Effects of phosphodiesterase type 5 inhibitor, tadalafil, on continence reflex in rats.

Authors:  Hideaki Izumi; Yasuhiro Kaiho; Minoru Miyazato; Naoki Kawamorita; Haruo Nakagawa; Yoichi Arai
Journal:  Int Urogynecol J       Date:  2014-07-03       Impact factor: 2.894

6.  Therapeutic effects of a soluble guanylate cyclase activator, BAY 60-2770, on lower urinary tract dysfunction in mice with spinal cord injury.

Authors:  Daisuke Gotoh; Tetsuichi Saito; Sergei Karnup; Yosuke Morizawa; Shunta Hori; Yasushi Nakai; Makito Miyake; Kazumasa Torimoto; Kiyohide Fujimoto; Naoki Yoshimura
Journal:  Am J Physiol Renal Physiol       Date:  2022-08-11

Review 7.  Phosphodiesterase-5 expression and function in the lower urinary tract: a critical review.

Authors:  Ching-Shwun Lin; Maarten Albersen; Zhongcheng Xin; Mikio Namiki; Dieter Muller; Tom F Lue
Journal:  Urology       Date:  2013-01-17       Impact factor: 2.649

8.  Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status.

Authors:  Yasuhiro Kaiho; Shinichi Yamashita; Akihiro Ito; Yoshihide Kawasaki; Hideaki Izumi; Naoki Kawamorita; Hisanobu Adachi; Koji Mitsuzuka; Yoichi Arai
Journal:  Investig Clin Urol       Date:  2016-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.